Ç÷°ü À̹Ì¡ ½ÃÀå, Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼ : ±â¼úº°, ½Ã¼úº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2032³â)
Vascular Imaging Market Share, Size, Trends, Industry Analysis Report, By Technique (Magnetic Resonance Imaging, Computed Tomography, X-Ray, Ultrasound, Nuclear Imaging, Others); By Procedure; By End Use; By Region; Segment Forecast, 2024- 2032
»óǰÄÚµå
:
1462979
¸®¼Ä¡»ç
:
Polaris Market Research
¹ßÇàÀÏ
:
2024³â 03¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 119 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¼¼°è Ç÷°ü À̹Ì¡ ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 90¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Á¶»ç º¸°í¼´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Â°ú ¹Ì·¡ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.
ÀÎÁöµµ Çâ»ó°ú °ËÁø ÇÁ·Î±×·¥ÀÌ Ç÷°ü ¿µ»ó ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. Á׻󵿸ưæÈÁõ, ¸»Ãʵ¿¸ÆÁúȯ°ú °°Àº Ç÷°ü Áúȯ¿¡ ´ëÇÑ ´ëÁßÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¿µ»óÁø´Ü ¼ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼¼°è °¢±¹ÀÇ Á¤ºÎ¿Í ÀÇ·á ±â°üÀº °í·ÉÀÚ ¹× ¸¸¼ºÁúȯÀÚ µî °íÀ§Ç豺À» ´ë»óÀ¸·Î ÇÑ °ËÁø ÀÌ´Ï¼ÅÆ¼ºê¸¦ ½ÃÇàÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÇÁ·Î±×·¥¿¡¼´Â Ç÷°ü °Ç° »óŸ¦ Æò°¡Çϰí ÀÌ»óÀ» °¨ÁöÇϱâ À§ÇØ ÃÊÀ½ÆÄ ¹× ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ Ç÷°ü Á¶¿µ¼ú°ú °°Àº ¹æ¹ýÀ» Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. ¿µ»ó Áø´Ü ±â¼úÀÇ ¹ßÀüÀ¸·Î Ç÷°ü À̹Ì¡ÀÌ º¸´Ù Ä£¼÷ÇÏ°í ´ú ħ½ÀÀûÀÌ µÇ¾î ´Ù¾çÇÑ ÀÓ»ó ÇöÀå¿¡¼ ¼±º°°Ë»ç ÇÁ·Î±×·¥ÀÇ ±¤¹üÀ§ÇÑ µµÀÔÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼ºñ½º Á¦°ø¾÷üµéÀÌ ¿¹¹æÀû Ä¡·á¿Í Á¶±â °³ÀÔÀ» ¿ì¼±½ÃÇÔ¿¡ µû¶ó Ç÷°ü ¿µ»ó ¼ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í Áõ°¡ÇÏ¿© ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
Ç÷°ü À̹Ì¡ ½ÃÀåÀº Àü ¼¼°è ÇコÄɾî ÁöÃâ Áõ°¡·Î ÀÎÇØ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. °æÁ¦°¡ ¹ßÀüÇÔ¿¡ µû¶ó ´õ ¸¹Àº ÀÚ¿øÀÌ ÇコÄɾ ÅõÀԵǰí ÀÖÀ¸¸ç, Ç÷°ü ¿µ»ó ½Ã½ºÅÛ°ú °°Àº ÷´Ü ÀÇ·á ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÇ·á ÁöÃâÀÇ ±ÞÁõÀº Áø´Ü ½Ã¼³ ¹× ¿µ»ó Áø´Ü¼¾Å͸¦ Æ÷ÇÔÇÑ ÀÇ·á ÀÎÇÁ¶óÀÇ È®Àå ¹× Çö´ëȸ¦ °¡´ÉÇÏ°Ô Çϰí, Ç÷°ü ¿µ»ó ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼ºñ½º Á¦°ø¾÷üµéÀº Áø´Ü Á¤È®µµ¸¦ ³ôÀ̰í, ȯÀÚ ¿¹Èĸ¦ °³¼±Çϸç, Ä¡·á °æ·Î¸¦ °£¼ÒÈÇϱâ À§ÇØ ÃÖ÷´Ü ¿µ»ó Áø´Ü ±â¹ýÀ» ¿ì¼±¼øÀ§¿¡ µÎ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÉÇ÷°ü Áúȯ Áõ°¡·Î ÀÎÇØ ¿¹¹æ, Áø´Ü ¹× Ä¡·á¿¡ ´ëÇÑ ÀÚ¿ø ¹èºÐÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Ç÷°ü ¿µ»ó ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
¿¬±¸ ¹× ÀÓ»ó½ÃÇèÀÇ ÀÀ¿ë ºÐ¾ß°¡ È®´ëµÇ¸é¼ Ç÷°ü À̹Ì¡ ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÃÊÀ½ÆÄ, CT Ç÷°üÁ¶¿µ¼ú(CTA), ÀÚ±â°ø¸í Ç÷°üÁ¶¿µ¼ú(MRA), Ç÷°üÁ¶¿µ¼ú°ú °°Àº ±â¼úÀº Ç÷°ü ÇØºÎÇÐ, »ý¸®ÇÐ, º´¸®ÇÐ ¿¬±¸¿¡ Á¡Á¡ ´õ ÇʼöÀûÀÎ ¿ä¼Ò°¡ µÇ°í ÀÖ½À´Ï´Ù. °íÇØ»óµµ ¿µ»óÀº Ç÷°üÀ» ¼¼¹ÐÇÏ°Ô ½Ã°¢ÈÇÏ¿© »õ·Î¿î Áø´Ü ¹× Ä¡·á Àü·«À» °³¹ßÇÏ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ¿¬±¸°³¹ß¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ÅõÀÚ¿Í ¿µ»ó Æò°¡ Ç׸ñ¿¡ ´ëÇÑ ±ÔÁ¦ °È·Î ÀÎÇØ ¿¬±¸ ¹× ÀÓ»ó½ÃÇè¿¡¼ Ç÷°ü ¿µ»ó ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.
Ç÷°ü ¿µ»ó¿¡¼ ÀΰøÁö´É°ú ¸Ó½Å·¯´×ÀÇ ÅëÇÕÀº Áø´Ü Á¤È®µµ, ¿öÅ©Ç÷οì È¿À²¼º, °³ÀÎÈµÈ È¯ÀÚ Ä¡·á¸¦ Çâ»ó½Ã۰í, AI¿Í ML ¾Ë°í¸®ÁòÀº Ç÷°ü ¿µ»ó ºÐ¼®À» ÀÚµ¿ÈÇÏ¿© ÀÌ»ó ¡Èĸ¦ ½Å¼ÓÇÏ°Ô °¨ÁöÇϰí Áúº´À» Á¤·®ÈÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÀÌ·¯ÇÑ ¾Ë°í¸®ÁòÀº °ú°Å »ç·Ê·ÎºÎÅÍ Áö¼ÓÀûÀ¸·Î ÇнÀÇÔÀ¸·Î½á °³º° ȯÀÚÀÇ Æ¯¼º¿¡ ¸Â°Ô ÀûÀÀÇÏ¿© ´õ ³ªÀº Ä¡·á °á°ú¸¦ À§ÇÑ ¸ÂÃãÇü Ä¡·á Àü·«À» ¼ö¸³ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »õ·Î¿î ¿µ»ó ¹ÙÀÌ¿À¸¶Ä¿ ¹× ¿¹Ãø ¸ðµ¨ °³¹ß¿¡ ±â¿©ÇÏ¿© Áúº´À» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.
Ç÷°ü À̹Ì¡ ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
CT(ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ) ºÐ¾ß´Â Ç÷°üÀÇ °íÇØ»óµµ 3Â÷¿ø ½Ã°¢È ¹× Ç÷°ü ÇØºÎÇп¡ ´ëÇÑ »ó¼¼ÇÑ Æò°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È Å« ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.
2023³â °ü»óµ¿¸Æ ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í °í·ÉÈ·Î ÀÎÇØ °ü»óµ¿¸Æ Á¶¿µ¼ú ºÎ¹®ÀÌ Å« ¸ÅÃâ ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
2023³â º´¿ø ºÎ¹®Àº ¸¹Àº ȯÀÚ ¼ö¿Í »õ·Î¿î ±â¼ú È®º¸·Î ÀÎÇØ º´¿ø ºÎ¹®ÀÌ Å« ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ºÏ¹Ì´Â ÷´Ü ÀÇ·á ÀÎÇÁ¶ó, ÷´Ü Áø´Ü ½Ã¼³¿¡ ´ëÇÑ Á¢±Ù¼º, ½ÉÇ÷°ü ÁúȯÀÇ ³ôÀº À¯º´·ü·Î ÀÎÇØ 2023³â Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Abbott Laboratories, Canon Medical Systems, Carestream Health, GE Healthcare, Hitachi Medical Systems, Hologic, Samsung Medicine, Shimadzu, Siemens HealthNeures µî ¼¼°èÀûÀÎ ½ÃÀå ÁøÃâ±â¾÷µéÀÌ Á¸ÀçÇϱ⠶§¹®¿¡ °æÀïÀº Ä¡¿ÇÕ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼·Ð
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå Á¶»ç ¹æ¹ý
Á¦4Àå ¼¼°èÀÇ Ç÷°ü À̹Ì¡ ½ÃÀå ÀλçÀÌÆ®
Ç÷°ü À̹Ì¡ ½ÃÀå - ½Ã¼ú ÇöȲ
Ç÷°ü À̹Ì¡ ½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀΰú ±âȸ
¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
PESTEL ºÐ¼®
Ç÷°ü À̹Ì¡ ½ÃÀå ½Ã¼ú µ¿Çâ
¹ë·ùüÀÎ ºÐ¼®
COVID-19ÀÇ ¿µÇ⠺м®
Á¦5Àå ±â¼úº° ¼¼°è ½ÃÀå
ÁÖ¿ä Á¶»ç °á°ú
¼·Ð
ÀÚ±â°ø¸í¿µ»ó
ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ
X¼±
ÃÊÀ½ÆÄ
ÇÙ¿µ»ó
±âŸ
Á¦6Àå ÃÖÁ¾ ¿ëµµº° ¼¼°è ½ÃÀå
ÁÖ¿ä Á¶»ç °á°ú
¼·Ð
º´¿ø
¿µ»óÁø´Ü¼¾ÅÍ
±âŸ
Á¦7Àå ½Ã¼úº° ¼¼°è ½ÃÀå
ÁÖ¿ä Á¶»ç °á°ú
¼·Ð
°ü»óµ¿¸Æ Á¶¿µ
³úÇ÷°ü Á¶¿µ °Ë»ç
Ç÷°ü ÃÊÀ½ÆÄ
¹Ì¼ÒÇ÷°ü Á¶¿µ °Ë»ç
¸»ÃÊÇ÷°ü Á¶¿µ°Ë»ç
±âŸ
Á¦8Àå Áö¿ªº° ¼¼°è ½ÃÀå
ÁÖ¿ä Á¶»ç °á°ú
¼·Ð
Ç÷°ü À̹Ì¡ ½ÃÀå Æò°¡, Áö¿ªº°, 2019-2032³â
Ç÷°ü À̹Ì¡ ½ÃÀå - ºÏ¹Ì
ºÏ¹Ì : Ç÷°ü À̹Ì¡ ½ÃÀå, ±â¼úº°, 2019³â-2032³â
ºÏ¹Ì : Ç÷°ü À̹Ì¡ ½ÃÀå, ½Ã¼úº°, 2019³â-2032³â
ºÏ¹Ì : Ç÷°ü À̹Ì¡ ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2019³â-2032³â
Ç÷°ü À̹Ì¡ ½ÃÀå - ¹Ì±¹
Ç÷°ü À̹Ì¡ ½ÃÀå - ij³ª´Ù
Ç÷°ü À̹Ì¡ ½ÃÀå - À¯·´
À¯·´ : Ç÷°ü À̹Ì¡ ½ÃÀå, ±â¼úº°, 2019³â-2032³â
À¯·´ : Ç÷°ü À̹Ì¡ ½ÃÀå, ½Ã¼úº°, 2019-2032³â
À¯·´ : Ç÷°ü À̹Ì¡ ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2019³â-2032³â
Ç÷°ü À̹Ì¡ ½ÃÀå - ¿µ±¹
Ç÷°ü À̹Ì¡ ½ÃÀå - ÇÁ¶û½º
Ç÷°ü À̹Ì¡ ½ÃÀå - µ¶ÀÏ
Ç÷°ü À̹Ì¡ ½ÃÀå - ÀÌÅ»¸®¾Æ
Ç÷°ü À̹Ì¡ ½ÃÀå - ½ºÆäÀÎ
Ç÷°ü À̹Ì¡ ½ÃÀå - ³×´ú¶õµå
Ç÷°ü À̹Ì¡ ½ÃÀå - ·¯½Ã¾Æ
Ç÷°ü À̹Ì¡ ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
¾Æ½Ã¾ÆÅÂÆò¾ç : Ç÷°ü À̹Ì¡ ½ÃÀå, ±â¼úº°, 2019-2032³â
¾Æ½Ã¾ÆÅÂÆò¾ç : Ç÷°ü À̹Ì¡ ½ÃÀå, ½Ã¼úº°, 2019³â-2032³â
¾Æ½Ã¾ÆÅÂÆò¾ç : Ç÷°ü À̹Ì¡ ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2019³â-2032³â
Ç÷°ü À̹Ì¡ ½ÃÀå - Áß±¹
Ç÷°ü À̹Ì¡ ½ÃÀå - Àεµ
Ç÷°ü À̹Ì¡ ½ÃÀå - ¸»·¹À̽þÆ
Ç÷°ü À̹Ì¡ ½ÃÀå - ÀϺ»
Ç÷°ü À̹Ì¡ ½ÃÀå - Àεµ³×½Ã¾Æ
Ç÷°ü À̹Ì¡ ½ÃÀå - Çѱ¹
Ç÷°ü À̹Ì¡ ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Ç÷°ü À̹Ì¡ ½ÃÀå, ±â¼úº°, 2019-2032³â
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Ç÷°ü À̹Ì¡ ½ÃÀå, ½Ã¼úº°, 2019-2032³â
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Ç÷°ü À̹Ì¡ ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2019-2032³â
Ç÷°ü À̹Ì¡ ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
Ç÷°ü À̹Ì¡ ½ÃÀå - UAE
Ç÷°ü À̹Ì¡ ½ÃÀå - À̽º¶ó¿¤
Ç÷°ü À̹Ì¡ ½ÃÀå - ³²¾ÆÇÁ¸®Ä«
Ç÷°ü À̹Ì¡ ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
¶óƾ¾Æ¸Þ¸®Ä« : Ç÷°ü À̹Ì¡ ½ÃÀå, ±â¼úº°, 2019³â-2032³â
¶óƾ¾Æ¸Þ¸®Ä« : Ç÷°ü À̹Ì¡ ½ÃÀå, ½Ã¼úº°, 2019-2032³â
¶óƾ¾Æ¸Þ¸®Ä« : Ç÷°ü À̹Ì¡ ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2019³â-2032³â
Ç÷°ü À̹Ì¡ ½ÃÀå - ¸ß½ÃÄÚ
Ç÷°ü À̹Ì¡ ½ÃÀå - ºê¶óÁú
Ç÷°ü À̹Ì¡ ½ÃÀå - ¾Æ¸£ÇîÆ¼³ª
Á¦9Àå °æÀï ±¸µµ
È®´ë¿Í Àμö ºÐ¼®
ÆÄÆ®³Ê½Ê/Çù¾÷/°è¾à/°ø°³
Á¦10Àå ±â¾÷ °³¿ä
Abbott Laboratories
Canon Medical Systems Corporation
Carestream Health
Esaote SpA
FUJIFILM Medical Systems
GE Healthcare
Hitachi Medical Systems
Hologic, Inc.
Koninklijke Philips N.V.
Mindray Medical International Limited
Samsung Medison
Shimadzu Corporation
Siemens Healthineers
Terason
Toshiba Medical Systems Corporation
LSH
¿µ¹® ¸ñÂ÷
The global vascular imaging market size is expected to reach USD 9.01 billion by 2032, according to a new study by Polaris Market Research. The report "Vascular Imaging Market Share, Size, Trends, Industry Analysis Report, By Technique (Magnetic Resonance Imaging, Computed Tomography, X-Ray, Ultrasound, Nuclear Imaging, Others); By Procedure; By End Use; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Increasing awareness and screening programs are fueling growth in the vascular imaging market. Heightened public awareness of vascular diseases like atherosclerosis and peripheral arterial disease has boosted demand for imaging services. Governments and healthcare organizations globally implement screening initiatives, targeting high-risk groups such as the elderly and those with chronic conditions. These programs utilize modalities like ultrasound and computed tomography angiography to assess vascular health and detect abnormalities. Advancements in imaging technology have made vascular imaging more accessible and less invasive, facilitating broader adoption of screening programs across various clinical settings. Healthcare providers prioritize preventive care and early intervention, further driving demand for vascular imaging services, thus contributing to market growth.
The vascular imaging market is expanding due to increasing global healthcare expenditure. As economies advance, more resources are channeled into healthcare, leading to heightened investments in advanced medical technologies like vascular imaging systems. This surge in healthcare spending enables the expansion and modernization of healthcare infrastructure, including diagnostic facilities and imaging centers, driving demand for vascular imaging technologies. Healthcare providers prioritize cutting-edge imaging modalities to enhance diagnostic accuracy, improve patient outcomes, and streamline treatment pathways. Moreover, the rising burden of cardiovascular diseases prompts increased allocation of resources toward prevention, diagnosis, and treatment, further propelling the demand for vascular imaging solutions.
Expanding applications in research and clinical trials are further fueling growth in the vascular imaging market. Techniques like ultrasound, computed tomography angiography (CTA), magnetic resonance angiography (MRA), and angiography are increasingly vital in studying vascular anatomy, physiology, and pathology. High-resolution imaging offers detailed vascular visualization, aiding the development of novel diagnostic and therapeutic strategies. With continuous investment in research and development and regulatory emphasis on imaging endpoints, the demand for vascular imaging technologies in research and clinical trials is set to rise, driving market expansion.
The integration of Artificial Intelligence and Machine Learning in the vascular imaging enhances diagnostic accuracy, workflow efficiency, and personalized patient care. AI and ML algorithms automate vascular image analysis, aiding in faster detection of abnormalities and disease quantification. Continuously learning from past cases, these algorithms adapt to individual patient characteristics, enabling tailored treatment strategies for better therapeutic outcomes. Additionally, they contribute to the development of novel imaging biomarkers and predictive models, facilitating early disease detection.
Vascular Imaging Market Report Highlights
The computed tomography segment is expected to experience significant growth during the forecast period owing to high-resolution, three-dimensional visualization of blood vessels and detailed assessment of vascular anatomy.
In 2023, the coronary angiography segment held a significant revenue share owing to the growing prevalence of coronary artery disease and the aging population.
In 2023, the hospitals segment held a significant revenue share owing to high patient volume and the acquisition of new technologies.
North America region accounted for a significant market share in 2023 due to advanced healthcare infrastructure, widespread access to cutting-edge diagnostic facilities, and a high prevalence of cardiovascular diseases.
The market is highly competitive owing to the existence of market players with a global presence, including Abbott Laboratories, Canon Medical Systems Corporation, Carestream Health, GE Healthcare, Hitachi Medical Systems, Hologic, Inc., Samsung Medison, Shimadzu Corporation, and Siemens Healthineers among others.
Polaris Market Research has segmented the Vascular Imaging market report based on technique, procedure, end use, and region:
Vascular Imaging, Technique Outlook (Revenue - USD Billion, 2019 - 2032)
Magnetic Resonance Imaging
Computed Tomography
X-Ray
Ultrasound
Nuclear Imaging
Others
Vascular Imaging, Procedure Outlook (Revenue - USD Billion, 2019 - 2032)
Coronary Angiography
Cerebral Angiography
Vascular Ultrasound
Microangiography
Peripheral Angiography
Others
Vascular Imaging, End Use Outlook (Revenue - USD Billion, 2019 - 2032)
Hospitals
Diagnostic Imaging Centers
Others
Vascular Imaging, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Netherlands
Spain
Russia
Asia Pacific
Japan
China
India
Malaysia
Indonesia
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Table of Contents
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
3. Research Methodology
3.1. Overview
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Vascular Imaging Market Insights
4.1. Vascular Imaging Market - Procedure Snapshot
4.2. Vascular Imaging Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising incidence of cardiovascular diseases is projected to spur the product demand
4.2.1.2. Growing aging population is expected to drive vascular imaging market growth
4.2.2. Restraints and Challenges
4.2.2.1. High cost of imaging equipment is likely to impede the market growth
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Vascular Imaging Market Procedure Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Vascular Imaging Market, by Technique
5.1. Key Findings
5.2. Introduction
5.2.1. Global Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
5.3. Magnetic Resonance Imaging
5.3.1. Global Vascular Imaging Market, by Magnetic Resonance Imaging, by Region, 2019-2032 (USD Billion)
5.4. Computed Tomography
5.4.1. Global Vascular Imaging Market, by Computed Tomography, by Region, 2019-2032 (USD Billion)
5.5. X-Ray
5.5.1. Global Vascular Imaging Market, by X-Ray, by Region, 2019-2032 (USD Billion)
5.6. Ultrasound
5.6.1. Global Vascular Imaging Market, by Ultrasound, by Region, 2019-2032 (USD Billion)
5.7. Nuclear Imaging
5.7.1. Global Vascular Imaging Market, by Nuclear Imaging, by Region, 2019-2032 (USD Billion)
5.8. Others
5.8.1. Global Vascular Imaging Market, by Others, by Region, 2019-2032 (USD Billion)
6. Global Vascular Imaging Market, by End Use
6.1. Key Findings
6.2. Introduction
6.2.1. Global Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
6.3. Hospitals
6.3.1. Global Vascular Imaging Market, by Hospitals, by Region, 2019-2032 (USD Billion)
6.4. Diagnostic Imaging Centers
6.4.1. Global Vascular Imaging Market, by Diagnostic Imaging Centers, by Region, 2019-2032 (USD Billion)
6.5. Others
6.5.1. Global Vascular Imaging Market, by Others, by Region, 2019-2032 (USD Billion)
7. Global Vascular Imaging Market, by Procedure
7.1. Key Findings
7.2. Introduction
7.2.1. Global Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
7.3. Coronary Angiography
7.3.1. Global Vascular Imaging Market, by Coronary Angiography, By Region, 2019-2032 (USD Billion)
7.4. Cerebral Angiography
7.4.1. Global Vascular Imaging Market, by Cerebral Angiography, By Region, 2019-2032 (USD Billion)
7.5. Vascular Ultrasound
7.5.1. Global Vascular Imaging Market, by Vascular Ultrasound, By Region, 2019-2032 (USD Billion)
7.6. Microangiography
7.6.1. Global Vascular Imaging Market, by Microangiography, By Region, 2019-2032 (USD Billion)
7.7. Peripheral Angiography
7.7.1. Global Vascular Imaging Market, by Peripheral Angiography, By Region, 2019-2032 (USD Billion)
7.8. Others
7.8.1. Global Vascular Imaging Market, by Others, By Region, 2019-2032 (USD Billion)
8. Global Vascular Imaging Market, by Geography
8.1. Key findings
8.2. Introduction
8.2.1. Vascular Imaging Market Assessment, By Geography, 2019-2032 (USD Billion)
8.3. Vascular Imaging Market - North America
8.3.1. North America: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.3.2. North America: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.3.3. North America: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.3.4. Vascular Imaging Market - U.S.
8.3.4.1. U.S.: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.3.4.2. U.S.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.3.4.3. U.S.: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.3.5. Vascular Imaging Market - Canada
8.3.5.1. Canada: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.3.5.2. Canada.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.3.5.3. Canada: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.4. Vascular Imaging Market - Europe
8.4.1. Europe: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.4.2. Europe.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.4.3. Europe: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.4.4. Vascular Imaging Market - UK
8.4.4.1. UK: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.4.4.2. UK.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.4.4.3. UK: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.4.5. Vascular Imaging Market - France
8.4.5.1. France: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.4.5.2. France.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.4.5.3. France: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.4.6. Vascular Imaging Market - Germany
8.4.6.1. Germany: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.4.6.2. Germany.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.4.6.3. Germany: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.4.7. Vascular Imaging Market - Italy
8.4.7.1. Italy: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.4.7.2. Italy.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.4.7.3. Italy: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.4.8. Vascular Imaging Market - Spain
8.4.8.1. Spain: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.4.8.2. Spain.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.4.8.3. Spain: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.4.9. Vascular Imaging Market - Netherlands
8.4.9.1. Netherlands: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.4.9.2. Netherlands.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.4.9.3. Netherlands: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.4.10. Vascular Imaging Market - Russia
8.4.10.1. Russia: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.4.10.2. Russia.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.4.10.3. Russia: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.5. Vascular Imaging Market - Asia Pacific
8.5.1. Asia Pacific: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.5.2. Asia Pacific.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.5.3. Asia Pacific: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.5.4. Vascular Imaging Market - China
8.5.4.1. China: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.5.4.2. China.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.5.4.3. China: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.5.5. Vascular Imaging Market - India
8.5.5.1. India: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.5.5.2. India.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.5.5.3. India: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.5.6. Vascular Imaging Market - Malaysia
8.5.6.1. Malaysia: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.5.6.2. Malaysia.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.5.6.3. Malaysia: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.5.7. Vascular Imaging Market - Japan
8.5.7.1. Japan: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.5.7.2. Japan.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.5.7.3. Japan: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.5.8. Vascular Imaging Market - Indonesia
8.5.8.1. Indonesia: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.5.8.2. Indonesia.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.5.8.3. Indonesia: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.5.9. Vascular Imaging Market - South Korea
8.5.9.1. South Korea: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.5.9.2. South Korea.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.5.9.3. South Korea: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.6. Vascular Imaging Market - Middle East & Africa
8.6.1. Middle East & Africa: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.6.2. Middle East & Africa.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.6.3. Middle East & Africa: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.6.4. Vascular Imaging Market - Saudi Arabia
8.6.4.1. Saudi Arabia: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.6.4.2. Saudi Arabia.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.6.4.3. Saudi Arabia: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.6.5. Vascular Imaging Market - UAE
8.6.5.1. UAE: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.6.5.2. UAE.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.6.5.3. UAE: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.6.6. Vascular Imaging Market - Israel
8.6.6.1. Israel: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.6.6.2. Israel.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.6.6.3. Israel: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.6.7. Vascular Imaging Market - South Africa
8.6.7.1. South Africa: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.6.7.2. South Africa.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.6.7.3. South Africa: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.7. Vascular Imaging Market - Latin America
8.7.1. Latin America: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.7.2. Latin America.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.7.3. Latin America: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.7.4. Vascular Imaging Market - Mexico
8.7.4.1. Mexico: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.7.4.2. Mexico.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.7.4.3. Mexico: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.7.5. Vascular Imaging Market - Brazil
8.7.5.1. Brazil: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.7.5.2. Brazil.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.7.5.3. Brazil: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
8.7.6. Vascular Imaging Market - Argentina
8.7.6.1. Argentina: Vascular Imaging Market, by Technique, 2019-2032 (USD Billion)
8.7.6.2. Argentina.: Vascular Imaging Market, by Procedure, 2019-2032 (USD Billion)
8.7.6.3. Argentina: Vascular Imaging Market, by End Use, 2019-2032 (USD Billion)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Abbott Laboratories
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. Canon Medical Systems Corporation
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. Carestream Health
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Esaote SpA
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. FUJIFILM Medical Systems
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. GE Healthcare
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Hitachi Medical Systems
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Hologic, Inc.
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Koninklijke Philips N.V.
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Mindray Medical International Limited
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
10.11. Samsung Medison
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Development
10.12. Shimadzu Corporation
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.12.4. Recent Development
10.13. Siemens Healthineers
10.13.1. Company Overview
10.13.2. Financial Performance
10.13.3. Product Benchmarking
10.13.4. Recent Development
10.14. Terason
10.14.1. Company Overview
10.14.2. Financial Performance
10.14.3. Product Benchmarking
10.14.4. Recent Development
10.15. Toshiba Medical Systems Corporation
10.15.1. Company Overview
10.15.2. Financial Performance
10.15.3. Product Benchmarking
10.15.4. Recent Development
°ü·ÃÀÚ·á